US Patent Issued to NANORA PHARMA on June 16 for "Methods of delivering anionic agents in vivo using non-viral nanoparticle-based delivery systems" (Canadian Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,905, issued on June 16, was assigned to NANORA PHARMA INC. (Montreal).

"Methods of delivering anionic agents in vivo using non-viral nanoparticle-based delivery systems" was invented by Satya Prakash (Brossard, Canada) and Meenakshi Malhotra (Montreal).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention concerns a polymeric material for the production of a non-viral nanoparticle. The polymeric material comprises (i) a hydrophilic linear polymer having a first end and a second end, (iii) a cross-linkable cationic polymer covalently bonded to the first end of the hydrophilic linear polymer, and (iii) at least one targeting/penetrating ...